Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Basilea Pharmaceutica AG (BPMUF) Return on Tangible Equity data is not available.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$303.84M |
|
$20.40M |
|
$35.02M |
|
$340.37M |
|
$59.40M |
|
$91.06M |
|
$112.40M |
|
$185.95M |
|
$154.43M |
|
$153.98M |
|
$154.43M |
|
-- |
|
| Cash Flow Statement Financials | |
$74.94M |
|
$-3.45M |
|
$-25.86M |
|
$150.34M |
|
$195.94M |
|
$45.60M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Tangible Equity |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|